Understanding the needs of different patient populations in CRC
EACCME®
Gastrointestinal Oncology30 min
Diagnosis and management of metastatic pancreatic ductal adenocarcinoma
Module 1 of 2
EACCME®
Gastrointestinal Oncology30 min
Chemotherapy strategies for metastatic pancreatic ductal adenocarcinoma
Module 2 of 2
EACCME®
Onco-genetics60 min
Precision oncology in practice – testing through to treatment in lung and prostate cancer
EACCME®
Onco-genetics30 min
Diagnosis and treatment of TRK fusion-positive lung cancer
EACCME®
Onco-genetics60 min
Diagnosing and treating TRK fusion-positive cancer
EACCME®
Onco-genetics60 min
TRK fusion-positive sarcomas and lung cancer
EACCME®
Onco-genetics60 min
The Role of PARP Inhibition in Prostate Cancer
EACCME®
Onco-genetics60 min
The Role of PARP inhibition in Clinical Practice
EACCME®
Cardiology60 min
Improving management through genetic testing for Familial Hypercholesterolaemia (FH)
EACCME®
Gastrointestinal Oncology30 min
Long term management of advanced colorectal cancer
EACCME®
Gastrointestinal Oncology60 min
Exploring the current gastroesophageal cancer treatment landscape and near-future developments
EACCME®
Gastrointestinal Oncology60 min
Toxicidades cutáneas relacionadas con la terapia dirigida en oncología hepática y gastrointestinal (ES)
EACCME® ACCME ABIM
Gastrointestinal Oncology60 min
Marco de Comunicación GUIDE (ES)
EACCME®
Gastrointestinal Oncology60 min
Skin Toxicities Related to Targeted Therapy in GI and Liver Oncology
EACCME® ACCME ABIM
Gastrointestinal Oncology60 min
GUIDE Communication Framework
EACCME®
Gastrointestinal Oncology60 min
The SHARE 5 Step Communication Framework for Shared Decision-Making in 3rd-Line Treatment of Metastatic Colorectal Cancer (mCRC)
EACCME®
Genitourinary Oncology30 min
Evolving landscape of PARP inhibitors in mCRPC: combination with anti-androgens
Module 2 of 2
EACCME®
Genitourinary Oncology30 min
PARP inhibitors in Advanced Prostate Cancer
Module 1 of 2
EACCME®
Genitourinary Oncology60 min
Incorporating PARP inhibitors into prostate cancer clinical practice
EACCME®
Genitourinary Oncology60 min
Targeting advanced prostate cancer with PARP inhibitors: Who, When and How?
EACCME®
Genitourinary Oncology60 min
PARP inhibitors in Prostate Cancer
EACCME®
Genitourinary Oncology30 min
Radiopharmaceuticals in prostate cancer
Episode 1: radium-223
EACCME®
Genitourinary Oncology30 min
Radiopharmaceuticals in prostate cancer
Episode 2: PSMA Theranostics
EACCME®
Genitourinary Oncology60 min
The SHARE Communication Framework Supporting Physicians In Shared Decision-Making With Patients Treated For Metastatic Castration Resistant Prostate Cancer (mCRPC)
EACCME®
Liver Oncology60 min
Treatment options for HCC patients who are not eligible for or progressed on IO
Clinical considerations and when to switch
EACCME®
Liver Oncology30 min
The use of immunotherapy in HCC
Module 2: in-depth subgroup analyses and challenges
EACCME®
Liver Oncology30 min
The use of immunotherapy in HCC
Module 1: efficacy and safety
EACCME®
Liver Oncology60 min
1st line monotherapy in advanced or unresectable HCC
EACCME®
Liver Oncology60 min
Appropriate selection of patients for combination immunotherapy in HCC: the now and the next
EACCME®
Neonatology / Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICU60 min
Blood Gases and Transcutaneous Monitoring (TCM) in the NICU and PICU
EACCME®
Neuroendocrine Tumours30 min
Tools for optimising treatment & management of advanced NETs
EACCME®
Neuroendocrine Tumours30 min
Recognising, Diagnosing and Managing Neuroendocrine Tumours
EACCME®
Neuroendocrine Tumours30 min
The role of SSA at progression
EACCME®
Hemato-oncology60 min
Optimising the management of multiple myeloma in the early relapsed/refractory setting (RRMM)
EACCME®
Hemostasis60 min
Managing thrombosis: podcast series
EACCME®
Hemostasis60 min
Normalising Haemostasis in Haemophilia - A new standard of care
EACCME®
Hemostasis30 min
Von Willebrand disease in the emergency care setting
EACCME®
Hemostasis30 min
Frauen mit Blutungsneigungen (DE)
Modul 1 - Wie man Blutungsneigungen bei Frauen und Mädchen erkennt
EACCME®
Hemostasis30 min
出血性疾患がある女性 (JA)
モジュ - ル1–女性および少女の出血性疾患を認識する方法
EACCME®
Hemostasis30 min
Frauen mit Blutungsneigungen (DE)
Modul 2 - Diagnostik und Behandlung von Frauen mit Blutungsneigungen
EACCME®
Hemostasis30 min
出血性疾患がある女性 (JA)
モジュ - ル2を完了すると、次のようになります
EACCME®
Hemostasis30 min
Mujeres con Trastornos Hemorrágicos (ES)
Módulo 1 - ¿Cómo reconocer y detectar trastornos hemorrágicos en mujeres y niñas?
EACCME®
Hemostasis30 min
Mujeres con Trastornos Hemorrágicos (ES)
Módulo 2 - Cómo diagnosticar y tratar a mujeres con trastornos hemorrágicos
EACCME®
Hemostasis30 min
Les troubles de la coagulation chez la femme (FR)
Module 1 – Comment identifier les troubles de la coagulation chez les femmes et les filles
EACCME®
Hemostasis30 min
Les troubles de la coagulation chez la femme (FR)
Module 2 - Comment diagnostiquer et traiter les femmes qui souffrent de troubles de la coagulation
EACCME®
Hemostasis30 min
How to care for a patient with von Willebrand disease
Module 3 of 3
EACCME®
Hemostasis30 min
How to screen for von Willebrand disease
Module 2 of 3
EACCME®
Hemostasis30 min
When to consider von Willebrand disease
Module 1 of 3
EACCME®
Hemostasis30 min
Women with Bleeding Disorders
Module 1 – How to recognise bleeding disorders in women and girls
EACCME®
Hemostasis30 min
Women with Bleeding Disorders
Module 2 - How to diagnose and manage women with bleeding disorders
EACCME®
Endocrinology60 min
Current perspectives on childhood growth disorders
EACCME®
Bone Diseases60 min
ASBMR 2021 Rare Bone Disease Highlights
EACCME®
Sarcoma30 min
Diagnosis and Management approach for Bone Sarcoma
EACCME®
Pediatrics30 min
Addressing diagnostic challenges of Severe Primary IGF-I Deficiency
EACCME®
Breast Cancer60 min
New oral endocrine therapy options for patients with advanced or metastatic ER+ breast cancer
All courses
EACCME®
ACCME
ABIM
